Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

REPAGLINIDE IMPURITY E CRS (10 MG)

REPAGLINIDE IMPURITY E CRS (10 MG)

NA

DISCOVER
TETRYZOLINE HYDROCHLORIDE CRS(15 MG)

TETRYZOLINE HYDROCHLORIDE CRS(15 MG)

522-48-5

DISCOVER
TORASEMIDE ANHYDROUS CRS (30 MG)

TORASEMIDE ANHYDROUS CRS (30 MG)

56211-40-6

DISCOVER
TORASEMIDE FOR SYSTEM SUITABILITY CRS (5 MG)

TORASEMIDE FOR SYSTEM SUITABILITY CRS (5 MG)

56211-40-6

DISCOVER
VINORELBINE TARTRATE CRS (50 MG)

VINORELBINE TARTRATE CRS (50 MG)

ND

DISCOVER
TICARCILLIN MONOSODIUM CRS (250 MG)

TICARCILLIN MONOSODIUM CRS (250 MG)

4697-14-7

DISCOVER
POVIDONE (IODINATED) CRS (10 MG)

POVIDONE (IODINATED) CRS (10 MG)

25655-41-8

DISCOVER
THIAMINE HYDROCHLORIDE CRS (10 MG)

THIAMINE HYDROCHLORIDE CRS (10 MG)

67-03-8

DISCOVER
BROTIZOLAM CRS - * PSY (10 MG)

BROTIZOLAM CRS - * PSY (10 MG)

57801-81-7

DISCOVER
BECLOMETASONE  DIPROPIONATE FOR PEAK IDENTIFICATION CRS (10

BECLOMETASONE DIPROPIONATE FOR PEAK IDENTIFICATION CRS (10

08/09/5534

DISCOVER
BROTIZOLAM IMPURITY B CRS (10MG)

BROTIZOLAM IMPURITY B CRS (10MG)

57801-97-5

DISCOVER
BUSPIRONE FOR SYSTEM SUITABILITY CRS (2 MG)

BUSPIRONE FOR SYSTEM SUITABILITY CRS (2 MG)

33386-08-2

DISCOVER